Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Cell Death Dis ; 11(8): 679, 2020 08 13.
Artigo em Inglês | MEDLINE | ID: mdl-32826848

RESUMO

Local renin-angiotensin system (RAS) in female reproductive system is involved in many physiological and pathological processes, such as follicular development, ovarian angiogenesis, ovarian, and endometrial cancer progress. However, studies on the functional relevance of RAS in human endometrium are limited, especially for renin-angiotensin-aldosterone system (RAAS). In this study, we defined the location of RAS components in human endometrium. We found that angiotensin II type-1 receptor (AT1R) and aldosterone synthase (CYP11B2), major components of RAAS, are specifically expressed in endometrial gland during mid-secretory phase. Aldosterone receptor, mineralocorticoid receptor (MR), is elevated in stroma in mid-secretory endometrium. In vitro, MR is also activated by aldosterone during decidualization. Activated MR initiates LKB1 expression, followed by phosphorylating of AMPK that stimulates PDK4 expression. The impact of PDK4 on decidualization is independent on PDHE1α inactivation. Based on co-immunoprecipitation, PDK4 interacts with p-CREB to prevent its ubiquitination for facilitating decidualization via FOXO1. Restrain of MR activation interrupts LKB1/p-AMPK/PDK4/p-CREB/FOXO1 pathway induced by aldosterone, indicating that aldosterone action on decidualization is mainly dependent on MR stimulation. Aldosterone biosynthesized in endometrial gland during mid-secretory phase promotes decidualization via activating MR/LKB1/p-AMPK/PDK4/p-CREB/FOXO1 signaling pathway. This study provides the valuable information for understanding the underlying mechanism during decidualization.


Assuntos
Aldosterona/farmacologia , Decídua/metabolismo , Endométrio/metabolismo , Quinases Proteína-Quinases Ativadas por AMP , Adenilato Quinase/metabolismo , Adulto , Linhagem Celular , Células Cultivadas , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico/metabolismo , Decídua/efeitos dos fármacos , Regulação para Baixo/efeitos dos fármacos , Endométrio/efeitos dos fármacos , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , Feminino , Proteína Forkhead Box O1/metabolismo , Glicólise/efeitos dos fármacos , Humanos , Ciclo Menstrual/efeitos dos fármacos , Modelos Biológicos , Fosforilação/efeitos dos fármacos , Gravidez , Progesterona/farmacologia , Proteínas Serina-Treonina Quinases/metabolismo , Receptores de Mineralocorticoides/metabolismo , Sistema Renina-Angiotensina/efeitos dos fármacos , Células Estromais/efeitos dos fármacos , Células Estromais/metabolismo , Canais de Cátion TRPP/metabolismo
2.
FEBS Lett ; 591(10): 1394-1407, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-28380254

RESUMO

The establishment of decidualization is a prerequisite of successful pregnancy. Lysyl oxidase (Lox) is a copper-containing amine oxidase which catalyzes cross-linking of collagen and elastin in the ECM. Lox is expressed in the subluminal stroma surrounding the implanting blastocyst on day 5 of pregnancy. From days 6 to 8, the signals for Lox mRNA and protein are strongly detected in the decidual cells. The expression of Lox is under the control of estrogen via the GSK-3ß/ß-catenin/c-myc pathway. Dtprp is decreased by the inhibition of Lox activity. Furthermore, the inhibition of Lox activity decreases stromal cell migration and embryo adhesion. Our findings highlight the crucial role of Lox in endometrial stromal cells and deepen our understanding of decidualization.


Assuntos
Blastocisto/metabolismo , Decídua/fisiologia , Proteínas da Matriz Extracelular/genética , Proteínas da Matriz Extracelular/metabolismo , Matriz Extracelular/metabolismo , Prolactina/análogos & derivados , Proteína-Lisina 6-Oxidase/genética , Proteína-Lisina 6-Oxidase/metabolismo , Animais , Movimento Celular , Implantação do Embrião , Estrogênios/metabolismo , Feminino , Regulação da Expressão Gênica no Desenvolvimento , Camundongos , Gravidez , Prolactina/metabolismo , Proteínas Proto-Oncogênicas c-myc/metabolismo , Células Estromais/citologia , Via de Sinalização Wnt , beta Catenina/metabolismo
3.
Sci Rep ; 6: 38134, 2016 12 07.
Artigo em Inglês | MEDLINE | ID: mdl-27924832

RESUMO

Polycystic ovary syndrome (PCOS), a complex endocrine disorder, is a leading cause of female infertility. An obvious reason for infertility in PCOS women is anovulation. However, success rate with high quality embryos selected by assisted reproduction techniques in PCOS patients still remain low with a high rate of early clinical pregnancy loss, suggesting a problem in uterine receptivity. Using a dehydroepiandrosterone-induced mouse model of PCOS, some potential causes of decreased fertility in PCOS patients were explored. In our study, ovulation problem also causes sterility in PCOS mice. After blastocysts from normal mice are transferred into uterine lumen of pseudopregnant PCOS mice, the rate of embryo implantation was reduced. In PCOS mouse uteri, the implantation-related genes are also dysregulated. Additionally, artificial decidualization is severely impaired in PCOS mice. The serum estrogen level is significantly higher in PCOS mice than vehicle control. The high level of estrogen and potentially impaired LIF-STAT3 pathway may lead to embryo implantation failure in PCOS mice. Although there are many studies about effects of PCOS on endometrium, both embryo transfer and artificial decidualization are applied to exclude the effects from ovulation and embryos in our study.


Assuntos
Desidroepiandrosterona/farmacologia , Síndrome do Ovário Policístico/induzido quimicamente , Síndrome do Ovário Policístico/fisiopatologia , Aborto Espontâneo/sangue , Aborto Espontâneo/fisiopatologia , Animais , Blastocisto/efeitos dos fármacos , Blastocisto/fisiologia , Implantação do Embrião/efeitos dos fármacos , Implantação do Embrião/fisiologia , Transferência Embrionária/métodos , Endométrio/efeitos dos fármacos , Endométrio/fisiologia , Estrogênios/sangue , Feminino , Infertilidade Feminina/sangue , Infertilidade Feminina/fisiopatologia , Masculino , Camundongos , Ovulação/efeitos dos fármacos , Ovulação/metabolismo , Ovulação/fisiologia , Síndrome do Ovário Policístico/sangue , Gravidez , Útero/efeitos dos fármacos , Útero/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA